Inhibikase Therapeutics I... (IKT)
NASDAQ: IKT
· Real-Time Price · USD
1.66
0.02 (1.22%)
At close: Oct 03, 2025, 3:59 PM
1.67
0.60%
After-hours: Oct 03, 2025, 06:35 PM EDT
13F Institute Ownership
Total Institutes of 46 in Inhibikase Therapeutics expanded their positions with an increase of 1 investors compared to the previous quarter. An additional 9.09M shares, as total invested capital grew by $6.85M with ownership percentage increasing from 50.62% to 60.77%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Sands Capital Ventures, LLC | 12.23% | 10.95M | +0.00% | 21.35M | 4.20% | Aug 13, 2025 |
| Soleus Capital Management, L.p... | 7.06% | 6.33M | +0.00% | 12.33M | 0.82% | Aug 15, 2025 |
| Fairmount Funds Management LLC | 6.84% | 6.13M | +0.00% | 11.94M | 1.55% | Aug 14, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.